Member European Parliament, Susana Solís Pérez visited Viralgen

On March 6, Susana Solís Pérez, Member of European Parliament, the Committee for Regional Development (REGI) and vice-president of the Delegation for Relations with the Korean Peninsula, among other responsibilities, visited Viralgen’s facilities.   Ms. Solís appreciated the great work being carried out by the company, both at the scientific and human level. She was…

A recent study by Clínica Ortiz-Vigón, Arrow Development and Thinking Perio Research sheds light on the use of resorbable materials in peri-implantitis treatments

The international journal of high impact in dentistry Journal of Clinical Periodontology, echoes one of the latest studies conducted by ThinkingPerio Research, Arrow Development & Clínica Ortiz-Vigón. The study analyzed the case of 43 patients diagnosed with peri-implantitis (bone loss around implants) and the results obtained shed light on the benefits or otherwise of the…

Mikrobiomik receives the ” Novel Company ” award, granted by El Correo and Banco Sabadell

Last Monday, February 20th, the company Mikrobiomik was awarded with the ” Novel Company ” prize, within the Euskadi Avanza Awards ceremony, organized by the most important local newspaper El Correo and Sabadell Bank . More than three hundred guests, businessmen and institutional representatives, attended the award ceremony of the sixth editi on, which took…

Viralgen receives cGMP certification to produce rAAV commercial grade product at new facility in San Sebastian, Spain

Certification expands Viralgen’s capacity threefold and positions the company as a worldleading CDMO. New facility operates single-use bioreactors from 50 to 2,000 liters and manufactures research, clinical and commercial grade rAAV vectors using Pro10™, the leading cell line on the market.   Viralgen Vector Core (Viralgen), an independently operated subsidiary of Asklepios BioPharmaceutical, Inc. (AskBio),…

Burdinola closes 2022 with a 70% increase in turnover and further increases its leadership in its strategic markets

The accumulated growth in recent years has led Burdinola S.Coop, a company dedicated to integral laboratory projects, to increase its turnover from €9 million in 2016 to €24 million in 2022. Its current workforce has grown from 89 to 130 people, approximately 75% of whom are indirect personnel. The geographical diversity of its projects means…

NEW STUDY TO IDENTIFY BIOMARKERS OF MILD COGNITIVE IMPAIRMENT ASSOCIATED WITH BREAST CANCER

The BCBL, in collaboration with the Onkologikoa-Biodonostia Foundation, leads a project to find markers linked to the cognitive side effects of the disease. The knowledge gained could help to design more personalized intervention strategies focused on specific deficits and to prevent sequelae. The initiative is funded by the Provincial Council of Gipuzkoa through the Gipuzkoa…

GAIKER is working on the development of innovative bioremediation technologies

The European project Symbiorem studies the simultaneous use of two or more bioremediation technologies to revitalize soils, sediments, surface water and groundwater.   Soil, sediment and water contamination is a problem that affects the quality of life, human health and the environment. There are different treatments to solve it, among them bioremediation, which is a…

Specialized media echo the latest review conducted by Arrow Development & Clínica Ortiz-Vigón, which delves into the diagnostic and therapeutic criteria for peri-implant pathologies.

Arrow Development & Clínica Ortiz-Vigón have just launched their latest study describing chronologically those aspects that allow a specialist to obtain an overview of peri-implant pathologies. For this purpose, Dr. Erik Regidor and Dr. Alberto Ortiz-Vigón -together with the rest of their periodontal therapy team- have based their work on the documentation of clinical cases…